Targeted GLUT-4 deficiency in the heart induces cardiomyocyte hypertrophy and impaired contractility linked with Ca(2+) and proton flux dysregulation.

[1]  T. Asano,et al.  Growth Hormone Inhibition of Glucose Uptake in Adipocytes Occurs without Affecting GLUT4 Translocation through an Insulin Receptor Substrate-2-Phosphatidylinositol 3-Kinase-dependent Pathway* , 2009, Journal of Biological Chemistry.

[2]  M. Cannell,et al.  Altered Calcium Homeostasis Does Not Explain the Contractile Deficit of Diabetic Cardiomyopathy , 2008, Diabetes.

[3]  F. Howarth,et al.  Myofilament sensitivity to Ca2+ in ventricular myocytes from the Goto–Kakizaki diabetic rat , 2008, Molecular and Cellular Biochemistry.

[4]  G K Smyth,et al.  Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper-responsiveness to substrate intervention. , 2008, Journal of molecular and cellular cardiology.

[5]  R. Witteles,et al.  Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. , 2008, Journal of the American College of Cardiology.

[6]  Jun Ren,et al.  Fidarestat improves cardiomyocyte contractile function in db/db diabetic obese mice through a histone deacetylase Sir2-dependent mechanism , 2007, Journal of hypertension.

[7]  H. Matsubara,et al.  Enhanced activity of ventricular Na+-HCO3- cotransport in pressure overload hypertrophy. , 2007, American journal of physiology. Heart and circulatory physiology.

[8]  E. Abel,et al.  Diabetic cardiomyopathy revisited. , 2007, Circulation.

[9]  R. Ritchie,et al.  The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo. , 2007, Journal of molecular and cellular cardiology.

[10]  W. Hsueh,et al.  Recipes for creating animal models of diabetic cardiovascular disease. , 2007, Circulation research.

[11]  F. Prunier,et al.  Enhanced activity of the myocardial Na+/H+ exchanger contributes to left ventricular hypertrophy in the Goto–Kakizaki rat model of type 2 diabetes: critical role of Akt , 2007, Diabetologia.

[12]  R. Marchase,et al.  Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart. , 2007, American journal of physiology. Cell physiology.

[13]  H. Cingolani,et al.  Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy. , 2007, Circulation.

[14]  Pawel Swietach,et al.  pH-Dependence of extrinsic and intrinsic H(+)-ion mobility in the rat ventricular myocyte, investigated using flash photolysis of a caged-H(+) compound. , 2007, Biophysical journal.

[15]  M. Mongillo,et al.  Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease. , 2006, Journal of the American College of Cardiology.

[16]  A. Ceylan-isik,et al.  Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch , 2006, Diabetologia.

[17]  I. Poornima,et al.  Diabetic cardiomyopathy: the search for a unifying hypothesis. , 2006, Circulation research.

[18]  K. Dutta,et al.  Cardiomyocyte dysfunction in insulin-resistant rats: a female advantage , 2006, Diabetologia.

[19]  S. Herzig,et al.  Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. , 2006, Diabetes.

[20]  F. Villarreal,et al.  The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[21]  H. Westerblad,et al.  Insulin and inositol 1,4,5-trisphosphate trigger abnormal cytosolic Ca2+ transients and reveal mitochondrial Ca2+ handling defects in cardiomyocytes of ob/ob mice. , 2005, Diabetes.

[22]  Qing Wang,et al.  Angiotensin II–Mediated Phenotypic Cardiomyocyte Remodeling Leads to Age-Dependent Cardiac Dysfunction and Failure , 2005, Hypertension.

[23]  L. Wold,et al.  Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats. , 2005, Journal of molecular and cellular cardiology.

[24]  E. Abel.  Myocardial insulin resistance and cardiac complications of diabetes. , 2005, Current drug targets. Immune, endocrine and metabolic disorders.

[25]  R. Malik,et al.  Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. , 2004, Clinical science.

[26]  D. Belke,et al.  Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. , 2004, Diabetes.

[27]  T. Tokudome,et al.  Direct effects of high glucose and insulin on protein synthesis in cultured cardiac myocytes and DNA and collagen synthesis in cardiac fibroblasts. , 2004, Metabolism: clinical and experimental.

[28]  R. Lerch,et al.  Insulin resistance in adult cardiomyocytes undergoing dedifferentiation: role of GLUT4 expression and translocation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  D. Gauguier,et al.  Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart. , 2004, Cardiovascular research.

[30]  A. Domenighetti,et al.  Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy. , 2003, Journal of molecular endocrinology.

[31]  R. Vaughan-Jones,et al.  Temperature dependence of Na+−H+ exchange, Na+−HCO3− co‐transport, intracellular buffering and intracellular pH in guinea‐pig ventricular myocytes , 2003, The Journal of physiology.

[32]  B. Woodward,et al.  Insulin-stimulated cytosol alkalinization facilitates optimal activation of glucose transport in cardiomyocytes. , 2002, American journal of physiology. Endocrinology and metabolism.

[33]  D. Severson,et al.  Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. , 2002, American journal of physiology. Heart and circulatory physiology.

[34]  L. Fliegel,et al.  H(2)O(2)-induced Ca(2+) overload in NRVM involves ERK1/2 MAP kinases: role for an NHE-1-dependent pathway. , 2002, American journal of physiology. Heart and circulatory physiology.

[35]  O. Frazier,et al.  Downregulation of Myocardial Myocyte Enhancer Factor 2C and Myocyte Enhancer Factor 2C-Regulated Gene Expression in Diabetic Patients With Nonischemic Heart Failure , 2002, Circulation.

[36]  S. Robinson,et al.  Effects of Na+/Ca2+-exchanger Overexpression on Excitation–contraction Coupling in Adult Rabbit Ventricular Myocytes , 2002 .

[37]  R. Tian,et al.  Responses of GLUT4-Deficient Hearts to Ischemia Underscore the Importance of Glycolysis , 2001, Circulation.

[38]  D. Severson,et al.  Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. , 2000, American journal of physiology. Endocrinology and metabolism.

[39]  G. Kotsanas,et al.  Stimulus interval-dependent differences in Ca2+ transients and contractile responses of diabetic rat cardiomyocytes. , 2000, Cardiovascular research.

[40]  B. Lowell,et al.  Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. , 1999, The Journal of clinical investigation.

[41]  D. Bers,et al.  Upregulation of Na(+)/Ca(2+) exchanger expression and function in an arrhythmogenic rabbit model of heart failure. , 1999, Circulation research.

[42]  R. Vaughan-Jones,et al.  Characterization of intracellular pH regulation in the guinea‐pig ventricular myocyte , 1999, The Journal of physiology.

[43]  G. Paternostro,et al.  Insulin resistance in patients with cardiac hypertrophy. , 1999, Cardiovascular research.

[44]  B. Rodrigues,et al.  Metabolic disturbances in diabetic cardiomyopathy , 1998, Molecular and Cellular Biochemistry.

[45]  D. Lagadic-Gossmann,et al.  Modulation by pH0 and intracellular Ca2+ of Na(+)-H+ exchange in diabetic rat isolated ventricular myocytes. , 1997, Circulation research.

[46]  D. Lagadic-Gossmann,et al.  Altered Ca2+ handling in ventricular myocytes isolated from diabetic rats. , 1996, The American journal of physiology.

[47]  V. Palmieri,et al.  Early abnormalities of cardiac function in non-insulin-dependent diabetes mellitus and impaired glucose tolerance. , 1995, The American journal of cardiology.

[48]  B. Alvarez,et al.  pHi regulation in myocardium of the spontaneously hypertensive rat. Compensated enhanced activity of the Na(+)-H+ exchanger. , 1995, Circulation research.

[49]  L. Becker,et al.  Functional coupling between glycolysis and sarcoplasmic reticulum Ca2+ transport. , 1995, Circulation research.

[50]  K. Spitzer,et al.  Relationship between intracellular pH and tension development in resting ventricular muscle and myocytes. , 1992, The American journal of physiology.

[51]  J. Kimura,et al.  Identification of sodium‐calcium exchange current in single ventricular cells of guinea‐pig. , 1987, The Journal of physiology.

[52]  B. Culver,et al.  Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice. , 2006, The Journal of endocrinology.

[53]  T. Opthof,et al.  Chronic inhibition of Na+/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure. , 2005, Cardiovascular research.

[54]  K. Philipson,et al.  Overexpression of the Na(+)/Ca(2+) exchanger and inhibition of the sarcoplasmic reticulum Ca(2+)-ATPase in ventricular myocytes from transgenic mice. , 2001, Cardiovascular research.

[55]  D. Bers,et al.  Steady-state twitch Ca2+ fluxes and cytosolic Ca2+ buffering in rabbit ventricular myocytes. , 1996, The American journal of physiology.

[56]  Thomas H Marwick,et al.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.